WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$4.35
−2.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 42.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.89x
- Price / sales
- 13.11x
- Price / cash flow
- -4.64x
Enterprise value
- Enterprise value
- $410.1M
- EV / sales
- 6.27x
- EV / EBITDA
- -2.08x
- EV / EBIT
- -1.88x
- Market cap
- $857.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026